Home
>
National Drug Code (NDC)
>
TIMENTIN
TIMENTIN - 0029-6579-21 - (ticarcillin disodium and clavulanate potassium)
Drug Information of TIMENTIN
| Product NDC: | 0029-6579 |
| Proprietary Name: | TIMENTIN |
| Non Proprietary Name: | ticarcillin disodium and clavulanate potassium |
| Active Ingredient(s): | 1; 30 mg/mL; mg/mL & nbsp; ticarcillin disodium and clavulanate potassium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TIMENTIN
| Product NDC: | 0029-6579 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050590 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19901022 |
Package Information of TIMENTIN
| Package NDC: | 0029-6579-21 |
| Package Description: | 10 VIAL, MULTI-DOSE in 1 TRAY (0029-6579-21) > 100 mL in 1 VIAL, MULTI-DOSE |
NDC Information of TIMENTIN
| NDC Code | 0029-6579-21 |
| Proprietary Name | TIMENTIN |
| Package Description | 10 VIAL, MULTI-DOSE in 1 TRAY (0029-6579-21) > 100 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 0029-6579 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ticarcillin disodium and clavulanate potassium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19901022 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM |
| Strength Number | 1; 30 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
